Indoco Remedies Files Compliance Certificate for Q3 FY26
Indoco Remedies Limited filed a compliance certificate for Q3 FY26 ended December 31, 2025. The Registrar and Transfer Agent confirmed processing of dematerialised securities and updates to the register of members within timelines. No rematerialisation requests were received.
This is a standard compliance filing as per SEBI regulations and does not involve any material event or financial disclosure that would significantly impact the company's stock or operations.
The announcement is a routine regulatory filing and does not contain any information that positively or negatively impacts the company's financial performance or business operations.
Indoco Remedies Limited has submitted a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2025. The certificate was issued by MUFG Intime India Private Limited, the company's Registrar and Transfer Agent.
The certificate confirms that securities received from depository participants for dematerialisation during the quarter were processed (accepted/rejected) and listed on the stock exchanges. It also states that the security certificates received for dematerialisation were mutilated and cancelled after verification, and the depositories' names were substituted in the register of members within the prescribed timelines. No requests for rematerialisation were received during this period.
The company requested the stock exchanges to take this information on record.
What to do with a filing like this
Indoco Remedies Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Indoco Remedies Limited. Read the original for the full detail.